Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis

Edvin Ingberg1, Hua Dock1, Elvar Theodorsson1

  • 1Division of Microbiology and Molecular Medicine, Department of Clinical and Experimental Medicine, Linköping University, Department of Clinical Chemistry, Center for Diagnostics, Region Östergötland, Sweden.

Scientific Reports
|February 16, 2016
PubMed

Insights

Optimizing preclinical stroke models is crucial for effective treatments. This meta-analysis identified mouse strains and occlusion methods that minimize infarct size variability and mortality in experimental stroke research.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Translational Medicine

Background:

  • Thrombolysis is the sole pharmacological treatment for ischemic stroke, despite numerous drug failures in clinical trials.
  • Preclinical study quality, particularly low statistical power, is implicated in the high failure rate of potential stroke therapies.
  • Optimizing animal models for reduced mortality and outcome variability is essential for reliable preclinical research.

Purpose of the Study:

  • To investigate the impact of methodological parameters on infarct size variability and mortality in experimental mouse stroke models.
  • To provide guidance for researchers aiming to enhance the reproducibility and predictive value of preclinical stroke studies.
  • To identify specific experimental conditions that minimize outcome variability and unnecessary animal loss.

Main Methods:

  • A hypothesis-driven meta-analysis was conducted using data extracted from 334 published experimental mouse stroke articles.
  • The study analyzed the influence of various methodological parameters on infarct size variability and mortality.
  • Key parameters investigated included mouse strain, occlusion method, and surgical techniques.

Main Results:

  • The use of Swiss and C57BL6 mice, combined with permanent middle cerebral artery occlusion, resulted in the lowest infarct size variability.
  • Embolic stroke models were found to increase infarct size variability.
  • Swiss mice exhibited higher mortality rates compared to other strains.

Conclusions:

  • Specific mouse strains and permanent middle cerebral artery occlusion methods are recommended for reducing variability in preclinical stroke research.
  • Researchers should carefully select experimental parameters to improve the reliability and efficiency of mouse stroke models.
  • This meta-analysis provides critical data to guide the optimization of experimental designs, ultimately aiming to improve the translation of preclinical findings to clinical applications.

Related Concept Videos